VillageMD valuation, funding and investors
VillageMD works in primary care services, based in United States. Founded in 2013, it has about 1,640 employees.
Growth Equity
VALUATION · TODAY
$590M +0% after Growth
Range $193M – $2.15B · Grade DTODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series A $36.0M
Growth $80.0M
Series B $100M
Growth $275M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,644 employees
−10%6m growth
−13%1y growth
−22%2y growth
1,000
2,000
3,000
Data from Jan 2021
Predicted in 1 yr $590M +0% vs today
Predicted next raise $271M if a round comes
Winding-down probability 82%
- Last round
- Growth · $275M · Jul 2020
- Valuation at last round
- $2.12B · implied
- Headcount
- 1,644 · down
- Grade
- D
- Founded
- 2013
VillageMD valuation today
VCMC values VillageMD at $590M today, with a range of $193M to $2.1B and a grade of D. The valuation starts from its last funding round, a growth round in Jul 2020.
Valuation by date (171 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2013 | $4.78M | $1.74M – $13.1M | $5.01M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $4.80M | $1.75M – $13.2M | $5.03M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $4.82M | $1.75M – $13.2M | $5.05M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $4.84M | $1.76M – $13.3M | $5.07M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $4.86M | $1.77M – $13.3M | $5.09M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $4.88M | $1.78M – $13.4M | $5.11M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $4.90M | $1.78M – $13.5M | $5.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $4.92M | $1.79M – $13.5M | $5.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $4.94M | $1.80M – $13.6M | $5.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $4.95M | $1.80M – $13.6M | $5.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $4.97M | $1.81M – $13.7M | $5.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $4.99M | $1.82M – $13.7M | $5.23M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $5.01M | $1.83M – $13.8M | $5.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $5.03M | $1.83M – $13.8M | $5.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $5.05M | $1.84M – $13.9M | $5.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $5.07M | $1.85M – $13.9M | $5.32M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $5.09M | $1.85M – $14.0M | $5.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $5.11M | $1.86M – $14.0M | $5.36M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2014 | $5.13M | $1.87M – $14.1M | $5.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2014 | $5.15M | $1.88M – $14.2M | $5.40M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2014 | $5.17M | $1.88M – $14.2M | $5.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2014 | $5.19M | $1.89M – $14.3M | $5.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2014 | $5.21M | $1.90M – $14.3M | $5.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2014 | $5.23M | $1.91M – $14.4M | $5.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2015 | $5.25M | $1.91M – $14.4M | $5.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.28M | $1.92M – $14.5M | $5.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.29M | $1.93M – $14.5M | $5.55M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.32M | $1.93M – $14.6M | $5.57M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.34M | $1.94M – $14.7M | $5.59M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.36M | $1.95M – $14.7M | $5.61M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.38M | $1.96M – $14.8M | $5.64M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.40M | $1.97M – $14.8M | $5.78M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.42M | $1.97M – $14.9M | $5.94M (+10%) | before first round | – | unknown | D | 0% |
| 17 Sep 2015 | $200M | $131M – $548M | $360M (+80%) | after a round | – | unknown | C | 0% |
| 1 Oct 2015 | $205M | $131M – $548M | $360M (+76%) | after a round | – | unknown | C | 0% |
| 1 Nov 2015 | $215M | $131M – $548M | $360M (+67%) | after a round | – | unknown | C | 0% |
| 1 Dec 2015 | $226M | $131M – $548M | $360M (+59%) | after a round | – | unknown | C | 0% |
| 1 Jan 2016 | $238M | $131M – $548M | $360M (+52%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $250M | $131M – $548M | $360M (+44%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $262M | $131M – $548M | $360M (+38%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $275M | $131M – $548M | $360M (+31%) | after a round | – | unknown | C | 0% |
| 1 May 2016 | $289M | $131M – $548M | $360M (+25%) | after a round | – | unknown | C | 0% |
| 1 Jun 2016 | $303M | $131M – $548M | $360M (+19%) | after a round | – | unknown | C | 0% |
| 1 Jul 2016 | $318M | $131M – $548M | $360M (+13%) | after a round | – | unknown | C | 0% |
| 1 Aug 2016 | $335M | $131M – $548M | $360M (+8%) | after a round | – | unknown | C | 0% |
| 1 Sep 2016 | $352M | $131M – $548M | $360M (+2%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $360M | $128M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $360M | $122M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $360M | $116M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $360M | $110M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $360M | $105M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $360M | $99.9M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $360M | $95.0M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $360M | $90.4M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $360M | $85.9M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $360M | $81.8M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $360M | $77.7M – $548M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $360M | $73.9M – $548M | $360M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2017 | $360M | $70.3M – $548M | $360M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2017 | $360M | $66.8M – $548M | $360M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2017 | $360M | $63.6M – $548M | $360M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2018 | $360M | $60.4M – $548M | $360M (0%) | after a round | – | unknown | D | 0% |
| 5 Jan 2018 | $777M | $548M – $1.2B | $855M (+10%) | after a round | – | unknown | B | 0% |
| 1 Feb 2018 | $783M | $548M – $1.2B | $855M (+9%) | after a round | – | unknown | B | 0% |
| 1 Mar 2018 | $789M | $548M – $1.2B | $855M (+8%) | after a round | – | unknown | B | 0% |
| 1 Apr 2018 | $795M | $548M – $1.2B | $855M (+8%) | after a round | – | unknown | B | 0% |
| 1 May 2018 | $801M | $548M – $1.2B | $855M (+7%) | after a round | – | unknown | B | 0% |
| 1 Jun 2018 | $808M | $548M – $1.2B | $855M (+6%) | after a round | – | unknown | B | 0% |
| 1 Jul 2018 | $814M | $548M – $1.2B | $855M (+5%) | after a round | – | unknown | B | 0% |
| 1 Aug 2018 | $821M | $548M – $1.2B | $855M (+4%) | after a round | – | unknown | B | 0% |
| 1 Sep 2018 | $827M | $548M – $1.2B | $855M (+3%) | after a round | – | unknown | B | 0% |
| 1 Oct 2018 | $834M | $548M – $1.2B | $855M (+3%) | after a round | – | unknown | B | 0% |
| 1 Nov 2018 | $841M | $548M – $1.2B | $855M (+2%) | after a round | – | unknown | B | 0% |
| 1 Dec 2018 | $847M | $548M – $1.2B | $855M (+1%) | after a round | – | unknown | B | 0% |
| 1 Jan 2019 | $854M | $548M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $855M | $523M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $855M | $500M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $855M | $475M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $855M | $452M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $855M | $430M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $855M | $409M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $855M | $389M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $855M | $369M – $1.2B | $855M (0%) | after a round | – | unknown | B | 0% |
| 5 Sep 2019 | $785M | $553M – $1.7B | $1.2B (+50%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $808M | $553M – $1.7B | $1.2B (+46%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $837M | $553M – $1.7B | $1.2B (+41%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $865M | $553M – $1.7B | $1.2B (+36%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $895M | $553M – $1.7B | $1.2B (+31%) | after a round | – | unknown | B | 0% |
| 1 Feb 2020 | $927M | $553M – $1.7B | $1.2B (+27%) | after a round | – | unknown | B | 0% |
| 1 Mar 2020 | $957M | $553M – $1.7B | $1.2B (+23%) | after a round | – | unknown | B | 0% |
| 1 Apr 2020 | $990M | $553M – $1.7B | $1.2B (+19%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $1.0B | $553M – $1.7B | $1.2B (+15%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $1.1B | $553M – $1.7B | $1.2B (+11%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $1.1B | $553M – $1.7B | $1.2B (+7%) | after a round | – | unknown | B | 0% |
| 9 Jul 2020 | $2.1B | $1.5B – $3.3B | $2.3B (+10%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $2.1B | $1.5B – $3.3B | $2.3B (+9%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $2.1B | $1.5B – $3.3B | $2.3B (+8%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $2.2B | $1.5B – $3.3B | $2.3B (+8%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $2.2B | $1.5B – $3.3B | $2.3B (+7%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $2.2B | $1.5B – $3.3B | $2.3B (+6%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $2.2B | $1.5B – $3.3B | $2.3B (+5%) | after a round | 510 | unknown | B | 0% |
| 1 Feb 2021 | $2.2B | $1.5B – $3.3B | $2.3B (+4%) | after a round | 510 | unknown | B | 0% |
| 1 Mar 2021 | $2.2B | $1.5B – $3.3B | $2.3B (+3%) | after a round | 510 | unknown | B | 0% |
| 1 Apr 2021 | $2.3B | $1.5B – $3.3B | $2.3B (+3%) | after a round | 510 | flat | B | 0% |
| 1 May 2021 | $2.3B | $1.5B – $3.3B | $2.3B (+2%) | after a round | 510 | flat | B | 0% |
| 1 Jun 2021 | $2.3B | $1.5B – $3.3B | $2.3B (+1%) | after a round | 510 | flat | B | 0% |
| 1 Jul 2021 | $2.3B | $1.5B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Aug 2021 | $2.3B | $1.4B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Sep 2021 | $2.3B | $1.4B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Oct 2021 | $2.3B | $1.3B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Nov 2021 | $2.3B | $1.2B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Dec 2021 | $2.3B | $1.2B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Jan 2022 | $2.3B | $1.1B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Feb 2022 | $2.3B | $1.1B – $3.3B | $2.3B (0%) | after a round | 510 | flat | B | 0% |
| 1 Mar 2022 | $2.9B | $1.7B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Apr 2022 | $2.9B | $1.7B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 May 2022 | $2.9B | $1.7B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Jun 2022 | $2.9B | $1.7B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Jul 2022 | $2.9B | $1.7B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Aug 2022 | $2.9B | $1.6B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Sep 2022 | $2.9B | $1.6B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Oct 2022 | $2.9B | $1.5B – $4.1B | $2.9B (0%) | after a round | 1,300 | growing | B | 0% |
| 1 Nov 2022 | $2.9B | $831M – $4.1B | $2.9B (0%) | after a round | 1,300 | unknown | C | 0% |
| 1 Dec 2022 | $2.9B | $791M – $4.1B | $2.9B (0%) | after a round | 1,300 | unknown | C | 0% |
| 1 Jan 2023 | $3.1B | $1.6B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Feb 2023 | $3.1B | $1.6B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Mar 2023 | $3.1B | $1.6B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Apr 2023 | $3.1B | $1.6B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 May 2023 | $3.1B | $1.6B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Jun 2023 | $3.1B | $1.5B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Jul 2023 | $3.1B | $1.5B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Aug 2023 | $3.1B | $1.3B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 Sep 2023 | $3.1B | $1.3B – $4.4B | $3.1B (0%) | after a round | 1,900 | growing | C | 0% |
| 1 Oct 2023 | $3.1B | $528M – $4.4B | $2.9B (-7%) | after a round | 2,000 | flat | D | 0% |
| 1 Nov 2023 | $3.1B | $502M – $4.3B | $2.9B (-7%) | after a round | 2,000 | flat | D | 0% |
| 1 Dec 2023 | $3.0B | $478M – $4.3B | $2.9B (-6%) | after a round | 2,000 | flat | D | 0% |
| 1 Jan 2024 | $3.0B | $454M – $4.3B | $2.9B (-5%) | after a round | 2,000 | flat | D | 0% |
| 1 Feb 2024 | $3.0B | $431M – $4.3B | $2.9B (-5%) | after a round | 2,000 | flat | D | 0% |
| 1 Mar 2024 | $3.0B | $411M – $4.2B | $2.9B (-4%) | after a round | 2,000 | flat | D | 0% |
| 1 Apr 2024 | $3.0B | $391M – $4.2B | $2.9B (-3%) | after a round | 2,000 | flat | D | 0% |
| 1 May 2024 | $2.9B | $372M – $4.2B | $2.9B (-3%) | after a round | 2,000 | flat | D | 0% |
| 1 Jun 2024 | $2.9B | $354M – $4.1B | $2.9B (-2%) | after a round | 2,000 | flat | D | 0% |
| 1 Jul 2024 | $3.0B | $464M – $4.2B | $2.9B (-3%) | after a round | 2,100 | up | D | 0% |
| 1 Aug 2024 | $2.9B | $323M – $4.1B | $2.9B (-1%) | after a round | 2,100 | flat | D | 0% |
| 1 Sep 2024 | $2.9B | $307M – $4.1B | $2.9B (0%) | after a round | 2,100 | flat | D | 0% |
| 1 Oct 2024 | $2.9B | $293M – $4.1B | $2.9B (0%) | after a round | 2,100 | flat | D | 0% |
| 1 Nov 2024 | $2.9B | $275M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Dec 2024 | $2.9B | $262M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Jan 2025 | $2.9B | $249M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Feb 2025 | $2.9B | $236M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Mar 2025 | $2.9B | $226M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Apr 2025 | $2.9B | $215M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 May 2025 | $2.9B | $204M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Jun 2025 | $2.9B | $201M – $4.1B | $2.9B (0%) | after a round | 2,000 | flat | D | 0% |
| 1 Jul 2025 | $1.6B | $199M – $3.9B | $1.6B (0%) | after a round | 1,912 | flat | D | 35% |
| 1 Aug 2025 | $1.5B | $199M – $3.9B | $1.3B (-9%) | after a round | 1,914 | flat | D | 40% |
| 1 Sep 2025 | $1.3B | $199M – $3.9B | $1.2B (-10%) | after a round | 1,893 | flat | D | 45% |
| 1 Oct 2025 | $1.2B | $199M – $3.9B | $1.1B (-11%) | after a round | 1,893 | down | D | 52% |
| 1 Nov 2025 | $1.1B | $198M – $3.8B | $925M (-13%) | after a round | 1,860 | down | D | 59% |
| 1 Dec 2025 | $1.1B | $198M – $3.8B | $925M (-13%) | after a round | 1,860 | down | D | 59% |
| 1 Jan 2026 | $940M | $198M – $3.8B | $806M (-14%) | after a round | 1,835 | down | D | 66% |
| 1 Feb 2026 | $1.0B | $198M – $3.8B | $879M (-13%) | after a round | 1,835 | down | D | 62% |
| 1 Mar 2026 | $1.1B | $198M – $3.8B | $965M (-12%) | after a round | 1,835 | flat | D | 57% |
| 1 Apr 2026 | $1.2B | $198M – $3.8B | $1.1B (-11%) | after a round | 1,835 | flat | D | 52% |
| 1 May 2026 | $811M | $194M – $3.7B | $682M (-16%) | after a round | 1,706 | down | D | 74% |
| 1 Jun 2026 | $894M | $194M – $3.7B | $763M (-15%) | after a round | 1,706 | down | D | 68% |
| 1 Jul 2026 | $978M | $194M – $3.8B | $845M (-14%) | after a round | 1,706 | down | D | 63% |
| 1 Aug 2026 | $929M | $194M – $2.6B | $929M (0%) | after a round | 1,706 | down | D | 58% |
| 1 Sep 2026 | $950M | $194M – $2.6B | $950M (0%) | after a round | 1,706 | down | D | 57% |
| 1 Oct 2026 | $590M | $193M – $2.1B | $590M (0%) | after a round | 1,644 | down | D | 82% |
| 24 Oct 2026 | $590M | $193M – $2.1B | $590M (0%) | after a round | 1,644 | down | D | 82% |
Key facts about VillageMD
- Founded
- 2013
- Headquarters
- United States
- Employees
- about 1,640 -13% in a year
- Total raised
- $491M
- Funding rounds
- 4
- Last round
- Growth Equity Jul 2020
VillageMD was founded in 2013 by Clive Fields, Paul Martino and Tim Barry.
VillageMD funding history
VillageMD has 4 funding rounds on record, from Sep 2015 to Jul 2020, $491M in total. None disclosed a valuation.
Growth Equity 8 Jul 2020
Led by Walgreens Boots Alliance; with Kinnevik. Individuals: georgi ganev.
Sources: finsmes.com, kinnevik.com, uk.finance.yahoo.com
$275M
Series B 4 Sep 2019
Led by Kinnevik; with Oak HC/FT, Town Hall Ventures, Adams Street Partners.
Sources: villagemd.com, villagemd.com
$100M
$80M
$36M
VillageMD investors
6 investors have backed VillageMD; Kinnevik, Oak HC/FT and Athyrium Capital Management and 1 more led at least one round.
- Kinnevik lead, 2 rounds
- Oak HC/FT lead, 2 rounds
- Walgreens Boots Alliance lead
- Adams Street Partners
What VillageMD does
VillageMD works in clinics - surgeons & physicians, with 13 recorded offerings and customers in healthcare.
Village Practice Management Company, LLC, known as VillageMD, is an American healthcare company engaged in value-based primary care, multispecialty care, and urgent care services. The company operates standalone and affiliated practices, including Village Medical, Village Medical at Walgreens, Village Medical at Home, Village Medical Pharmacy, and Village Medical Physical Therapy, serving patients in clinics, patient homes, and online. VillageMD also provides a proprietary care platform that integrates data to support providers and patients, and manages a network of practice locations across the United States.
Description from Veridion's company data.
Products and services
- Primary Care Services
- Multispecialty Care Services
- Urgent Care Services
- Home-Based Healthcare Services
- Virtual Healthcare Services
- Pharmacy Services
- Physical Therapy Services
- Value-Based Care Solutions
- Population Health Data Analytics
- Healthcare Staffing Services
- Practice Management Consulting
- Healthcare Technology Platform Development
- Equitable Patient Access Solutions
Markets
- Healthcare
Business model
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621111 Offices of Physicians (except Mental Health Specialists) 85% match
- 456110 Pharmacies and Drug Retailers 15% match
Questions about VillageMD
What is VillageMD worth?
Valuation $590M (range $193M to $2.1B), as of 24 Oct 2026.
Has VillageMD raised money?
VillageMD has 4 funding rounds on record, from Sep 2015 to Jul 2020, $491M in total. None disclosed a valuation.
Who has invested in VillageMD?
Kinnevik, Oak HC/FT, Athyrium Capital Management, Walgreens Boots Alliance, Adams Street Partners and Town Hall Ventures. Lead investors include Kinnevik, Oak HC/FT, Athyrium Capital Management and Walgreens Boots Alliance.
How many people work at VillageMD?
About 1,640, down 13% over the last year. Headcount rose from 510 in Jan 2021 to 2,100 in Jul 2024, then fell to 1,644 in Sep 2026.
What does VillageMD do?
VillageMD works in clinics - surgeons & physicians, with 13 recorded offerings and customers in healthcare. Its main offerings are primary care services, multispecialty care services and urgent care services.
When was VillageMD founded, and where is it based?
VillageMD was founded in 2013 and is based in United States. It has about 1,640 employees, down 13% over the last year.